FEATURED COMPANIES
- Abbott Laboratories
- Bosch Limited
- F. Hoffmann-La Roche Ltd
- Getinge AB
- Koninklijke Philips N.V.
- NIHON KOHDEN CORPORATION
Key Questions Answered in the Report:
- What are the major market drivers, challenges, and opportunities in the global patient monitoring solutions market?
- What is the global patient monitoring solutions market size in terms of revenue from 2018-2028?
- How is each segment of the global patient monitoring solutions market expected to grow during the forecast period and what is the revenue expected to be generated by each of the segments by the end of 2028?
- What are the key development strategies implemented by the key major players to sustain in the competitive market?
- What is the growth potential of the patient monitoring solutions market in each region, namely, North America, Europe, Asia-Pacific, and the Rest-of-the-World?
- Which products (hemodynamic, cardiac, respiratory, and neuromonitoring devices) are offered by key players such as GE Healthcare, Medtronic plc, Biotronik Scientific Corporation, Koninklijke Philips N.V., and Johnson & Johnson?
- What is the market share of major companies in the global patient monitoring solutions market?
- Which product is currently dominating the global patient monitoring solutions market and why?
- Which application and end-user of the global patient monitoring solutions market are dominant in the forecast period?
The Global Patient Monitoring Solutions Market report projects the market to grow at a significant CAGR of 6.50% during the forecast period from 2019 to 2028. The market has evolved dramatically with the rise in the adoption rate of remote monitoring devices, an increasing number of geriatric populations, and the growing prevalence of chronic diseases. Despite the benefits offered by the patient monitoring technology, the major challenges in the market are the high cost of technology, risks associated with monitoring devices and lack of security of patient data and health information safety concerns. Some of the major opportunities for the key vendors in the market could be a growing demand for monitoring devices from non-hospital settings and growing investments in healthcare IT.
Expert Quote
“North America is the leading contributor to the global patient monitoring solutions market. In 2018, in terms of revenue, the North America patient monitoring solutions market is anticipated to grow at a significant CAGR during the forecast period. This double-digit growth can be attributed to the rising demand for home-based monitoring devices and increasing investment in healthcare IT. However, Asia-Pacific is the fastest-growing region during the forecast period, because of the rising prevalence of chronic diseases such as diabetes, and hypertension and rising demand for home-based monitoring devices.”
Scope of the Global Patient Monitoring Solutions Market
The purpose of this study is to gain a holistic view of the global patient monitoring solutions market in terms of various influencing factors such as regional adoption trends, and technological advancements.
The scope of this report constitutes an in-depth study of the global patient monitoring solutions market, including a thorough analysis of the products in the market as well as their adoption spanning different geographical regions. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.
Market Segmentation
The global patient monitoring solutions market is segmented based on products (hemodynamic, cardiac, neuromonitoring, respiratory, diabetes, and temperature monitoring device), applications (hematology, cardiology, respiratory, neurology, metabolics, and temperature), and end-user (hospital-based patients, ambulatory based patients, and home healthcare patients), and region (North America, Europe, Asia-Pacific, and Rest-of-the-World (Latin America and Middle East & Africa).
As of 2018, the global patient monitoring solutions market was estimated to be approximately $19.30 billion and is expected to grow with a double-digit CAGR during the forecast period. North America dominated the patient monitoring solutions market among other regions.
Factors contributing to the growth of the North America patient monitoring solutions market include rising demand for home-based monitoring devices and increasing investment in healthcare IT. Asia-Pacific held the second largest contributor for the patient monitoring solutions market, due to the increasing prevalence of chronic conditions such as diabetes and hypertension and rising demand for home-based monitoring devices.
By Product, the cardiac monitoring device held 24.62% of the total market share in 2018 and is expected to grow in the upcoming years. The growth in the segment can be attributed to the availability of blood pressure measuring devices in the hospitals, coupled with other factors.
By applications, the hematology segment held the largest market share followed by the cardiology segment in 2018. By End-User, the hospital-based patients’ segment is however expected to dominate the market attributing to the patients undergo surgery in the hospitals and hence they need continuous monitoring of the vital signs and their disease condition. Therefore, increasing usage of monitoring devices to hospital-based patients.
Key Companies in the Global Patient Monitoring Solutions Market
The report also profiles 19 key players from the patient monitoring solutions market. Some of the market players include primary and secondary data analysis tools providers such as Medtronic plc, Koninklijke Philips N.V., Abbott Laboratories, F. Hoffmann-La Roche AG, General Electric Company, Omron Corporation, Nihon Kohden Corporation, Boston Scientific Corporation, and Biotronik. There are a plethora of companies providing different products such as Medtronic plc, Natus Medical, and Drägerwerk AG & Co. KGaA.
FEATURED COMPANIES
- Abbott Laboratories
- Bosch Limited
- F. Hoffmann-La Roche Ltd
- Getinge AB
- Koninklijke Philips N.V.
- NIHON KOHDEN CORPORATION
Executive Summary
1 Market Overview
1.1 Introduction
2 Market Dynamics
2.1 Introduction
2.2 Impact Analysis
2.3 Market Drivers
2.3.1 Rise in Adoption Rate of Remote Patient Monitoring Devices/ Availability of Wireless Monitoring Devices
2.3.2 Rising Incidence of Lifestyle and Chronic Diseases
2.3.3 Government Regulations
2.3.4 Ease of Use and Portability Devices to Promote the Growth
2.3.5 Growth in Geriatric Population
2.4 Market Restraints
2.4.1 Resistance from Healthcare Industry Professionals toward the Adoption of Patient Monitoring Systems
2.4.2 High Cost of Technology
2.4.3 Lack of Security of Patient Data and Health Information Safety Concerns
2.4.4 Risks Associated with Monitoring Devices
2.5 Market Opportunities
2.5.1 Growing Demand for Patient Monitoring Devices in Non-Hospital Settings
2.5.2 Emerging Markets
2.5.3 Growing Investments in Healthcare IT
3 Competitive Landscape
3.1 Key Strategies and Developments
3.1.1 Collaborations, Partnerships, and Agreements
3.1.2 Product Launches and Enhancements
3.1.3 Acquisitions
3.1.4 Awards and Fundings
3.1.5 Product Approvals
3.1.6 Business Expansion Activities
3.2 Market Share Analysis
3.2.1 Market Share Analysis (by Company)
4 Industry Insights
4.1 Patent Analysis
4.2 Regulatory Requirements
4.3 Bills, Acts, and Alliances for Patient Monitoring Solution
5 Global Patient Monitoring Solutions Market (by Product)
5.1 Hemodynamic Monitoring Devices
5.2 Cardiac Monitoring Devices
5.3 Respiratory Monitoring Devices
5.4 Neuromonitoring Devices
5.5 Diabetes Monitoring Devices
5.6 Temperature Monitoring Devices
6 Global Patient Monitoring Solutions Market (by Applications)
6.1 Hematology
6.2 Cardiology
6.3 Respiratory
6.4 Neurology
6.5 Metabolics
6.6 Temperature
7 Global Patient Monitoring Solutions Market (by End-User)
7.1 Hospital Based Patients
7.2 Ambulatory Based Patients
7.3 Home Healthcare Patients
8 Global Patient Monitoring Solutions Market (by Region)
8.1 North America
8.1.1 North America: Patient Monitoring Solutions Market (by Country)
8.1.1.1 U.S.
8.1.1.2 Canada
8.2 Europe
8.2.1 Europe: Patient Monitoring Solutions Market (by Country)
8.2.1.1 Germany
8.2.1.2 U.K.
8.2.1.3 France
8.2.1.4 Italy
8.2.1.5 Spain
8.2.1.6 Netherlands
8.2.1.7 Rest-of-Europe
8.3 Asia-Pacific (APAC)
8.3.1 Asia-Pacific: Patient Monitoring Solutions Market (by Country)
8.3.1.1 Japan
8.3.1.2 China
8.3.1.3 Australia
8.3.1.4 India
8.3.1.5 South Korea
8.3.1.6 Rest-of-Asia-Pacific
8.4 Rest-of-the-World
8.4.1 Rest-of-the-World: Patient Monitoring Solutions Market (by Country)
8.4.1.1 Latin America
8.4.1.2 Middle East & Africa
9 Company Profiles
9.1 Overview
9.2 Medtronic plc
9.2.1 Company Overview
9.2.2 Role of Medtronic plc in the Global Patient Monitoring Solutions Market
9.2.3 Financials
9.2.4 Key Insights about Financial Health of the Company
9.2.5 SWOT Analysis
9.3 General Electric Company
9.3.1 Company Overview
9.3.2 Role of General Electric in the Global Patient Monitoring Solutions Market
9.3.3 Financials
9.3.4 Key Insights on the Financial Health of the Company
9.3.5 SWOT Analysis: General Electric Company
9.4 Koninklijke Philips N.V.
9.4.1 Company Overview
9.4.2 Role of Koninklijke Philips N.V. in the Global Patient Monitoring Solutions Market
9.4.3 Financials
9.4.4 Key Insights on the Financial Health of the Company
9.4.5 SWOT Analysis: Koninklijke Philips N.V.
9.5 Drägerwerk AG & Co. KGaA
9.5.1 Company Overview
9.5.2 Role of Drägerwerk AG & Co. KGaA in the Global Patient Monitoring Solutions Market
9.5.3 Financials
9.5.4 SWOT Analysis
9.6 Abbott Laboratories
9.6.1 Company Overview
9.6.2 Role of Abbott Laboratories in the Global Patient Monitoring Solutions Market
9.6.3 Financials
9.6.4 Key Insights about Financial Health of the Company
9.6.5 SWOT Analysis
9.7 Johnson & Johnson
9.7.1 Company Overview
9.7.2 Role of Johnson & Johnson in the Global Patient Monitoring Solutions Market
9.7.3 Financials
9.7.4 Key Insights about Financial Health of the Company
9.7.5 SWOT Analysis
9.8 F. Hoffmann-La Roche Ltd
9.8.1 Company Overview
9.8.2 Role of F. Hoffmann-La Roche AG in the Global Patient Monitoring Solutions Market
9.8.3 Financials
9.8.4 Key Insights about Financial Health of the Company
9.8.5 SWOT Analysis
9.9 Boston Scientific Corporation
9.9.1 Company Overview
9.9.2 Role of Boston Scientific Corporation in the Patient Monitoring Solutions Market
9.9.3 Financials
9.9.4 Key Insights about Financial Health of the Company
9.9.5 SWOT Analysis
9.10 Edwards Lifesciences Corporation
9.10.1 Company Overview
9.10.2 Role of Edwards Lifesciences Corporation in the Patient Monitoring Solutions Market
9.10.3 Financials
9.10.4 Key Insights about Financial Health of the Company
9.10.5 SWOT Analysis
9.11 NIHON KOHDEN CORPORATION
9.11.1 Company Overview
9.11.2 Role of NIHON KOHDEN CORPORATION in the Patient Monitoring Solutions Market
9.11.3 Financials
9.11.4 Key Insights about Financial Health of the Company
9.11.5 SWOT Analysis
9.12 Omron Corporation
9.12.1 Company Overview
9.12.2 Role of Omron Corporation in the Global Patient Monitoring Solutions Market
9.12.3 Financials
9.12.4 Key Insights about Financial Health of the Company
9.12.5 SWOT Analysis
9.13 Bosch Limited
9.13.1 Company Overview
9.13.2 Role of Bosch Limited in the Global Patient Monitoring Solutions Market
9.13.3 Financials
9.13.4 Key Insights about Financial Health of the Company
9.13.5 SWOT Analysis
9.14 Becton, Dickinson and Company
9.14.1 Company Overview
9.14.2 Role of Becton, Dickinson and Company in the Global Patient Monitoring Solutions Market
9.14.3 Financials
9.14.4 Key Insights about Financial Health of the Company
9.14.5 SWOT Analysis
9.15 Biotronik
9.15.1 Company Overview
9.15.2 Role of Biotronik in the Global Patient Monitoring Solutions Market
9.15.3 SWOT Analysis
9.16 Welch Allyn
9.16.1 Company Overview
9.16.2 Role of Welch Allyn in the Global Patient Monitoring Solutions Market
9.16.3 SWOT Analysis
9.17 Smiths Medical, Inc.
9.17.1 Company Overview
9.17.2 Role of Smiths Medical, Inc. in the Global Patient Monitoring Solutions Market
9.17.3 SWOT Analysis
9.18 Getinge AB
9.18.1 Company Overview
9.18.2 Role of Getinge AB in the Patient Monitoring Solutions Market
9.18.3 SWOT Analysis
9.19 Spacelabs Healthcare
9.19.1 Company Overview
9.19.2 Role of Spacelabs Healthcare in the Global Patient Monitoring Solutions Market
9.19.3 SWOT Analysis
10 Research Scope and Methodology
10.1 Research Scope
10.2 Research Methodology
List of Tables
Table 2.1: Impact Analysis of Market Drivers
Table 2.2: Impact analysis of Market Restraints
Table 4.1: Global Patient Monitoring Solutions Market: Patent Analysis
Table 4.2: List of Major Regulatory Bodies and Associations across the World
Table 4.3: Some of the Bills, and Acts for Patient Monitoring Solutions
Table 5.1: Competitive Benchmarking by Product
List of Figures
Figure 1: Drivers and Restraints of Global Patient Monitoring Solutions Market
Figure 2: Share of Key Developments and Strategies, January 2016-September 2019
Figure 3: Market Share Analysis for the Global Patient Monitoring Solutions Market, by Company (2018)
Figure 4: Market Share Analysis for the Global Patient Monitoring Solutions Market, by Company (2018)
Figure 5: Global Patient Monitoring Solutions Market Value, 2017-2028
Figure 6: Global Patient Monitoring Solutions Market (by Product):2017-2028
Figure 7: Global Patient Monitoring Solutions Market (by Applications): 2017-2028
Figure 8: Global Patient Monitoring Solutions Market (by End-User): 2017-2028
Figure 9: Global Patient Monitoring Solutions Market (by Region), 2018 and 2028
Figure 1.1: Global Patient Monitoring Solutions Market, 2017-2028
Figure 2.1: Wireless Sharing of Patient Data
Figure 2.2: Percentage of Health Care Spending by Number of Chronic Conditions
Figure 2.3: Percentage of Population with Chronic Conditions
Figure 2.4: The Centers for Disease Control and Prevention (CDC) Statistics
Figure 2.5: Leading Chronic Diseases
Figure 2.6: Percentage of Chronic Conditions
Figure 2.7: Remote Patient Monitoring
Figure 3.1: Competitive Landscape, January 2016-September 2019.
Figure 3.2: Key Strategies and Developments, January 2016-September 2019.
Figure 3.3: Share of Key Developments and Strategies, January 2016-September 2019
Figure 3.4: Collaborations, Partnerships, and Agreements share (by Company), January 2016-September 2019
Figure 3.5: Product Launches and Enhancements Share (by Company), January 2016-September 2019
Figure 3.6: Acquisitions share (by Company), January 2016-September 2019
Figure 3.7: Product Launches and Enhancements share (by Company), January 2016-September 2019
Figure 3.8: Product Approvals share (by Company), January 2016-September 2019
Figure 3.9: Business Expansion and Others share (by Company), January 2016-
Figure 3.10: Market Share Analysis for the Global Patient Monitoring Solutions Market, by Company (2018)
Figure 5.1: Global Patient Monitoring Solutions Market (by Product)
Figure 5.2: Global Patient Monitoring Solutions Market (by Product), 2017-2028
Figure 5.3: Global Patient Monitoring Solutions Market: Hemodynamic Monitoring Devices: 2017-2028
Figure 5.4: Global Patient Monitoring Solutions Market: Cardiac Monitoring Devices: 2017-2028
Figure 5.5: Global; Patient Monitoring Solutions Market: Respiratory Monitoring Devices: 2017-2028
Figure 5.6: Global; Patient Monitoring Solutions Market: Neuromonitoring Devices: 2017-2028
Figure 5.7: Global Patient Monitoring Solutions Market: Diabetes Monitoring Devices: 2017-2028
Figure 5.8: Global; Patient Monitoring Solutions Market: Temperature Monitoring Devices: 2017-2028
Figure 6.1: Segmentation of Patient Monitoring Solutions Market, by Applications
Figure 6.2: Global Patient Monitoring Solutions Market (by Applications), 2017-2028
Figure 6.3: Global Patient Monitoring Solutions Market: Hematology: 2017-2028
Figure 6.4: Global Patient Monitoring Solutions Market: Cardiology: 2017-2028
Figure 6.5: Global Patient Monitoring Solutions Market: Respiratory: 2017-2028
Figure 6.6: Global Patient Monitoring Solutions Market: Neurology: 2017-2028
Figure 6.7: Global Patient Monitoring Solutions Market: Metabolics: 2017-2028
Figure 6.8: Global Patient Monitoring Solutions Market: Temperature: 2017-2028
Figure 7.1: Segmentation of Patient Monitoring Solutions Market, by End-User
Figure 7.2: Global Patient Monitoring Solutions Market (by End-User), 2017-2028
Figure 7.3: Global Patient Monitoring Solutions Market: Hospital-Based Patients: 2017-2028
Figure 7.4: Global Patient Monitoring Solutions Market: Ambulatory Patients: 2017-2028
Figure 7.5: Global Patient Monitoring Solutions Market: Home Healthcare Patients: 2017-2028
Figure 8.1: Global Patient Monitoring Solutions Market (by Region), 2018 and 2028
Figure 8.2: North America: Patient Monitoring Solutions Market, 2017-2028
Figure 8.3: North America: Market Dynamics
Figure 8.4: North America: Patient Monitoring Solutions Market (by Country), 2018 and 2028
Figure 8.5: The U.S.: Patient Monitoring Solutions Market: 2017-2028
Figure 8.6: Canada Patient Monitoring Solutions Market, 2017-2028
Figure 8.7: Europe Patient Monitoring Solutions Market, 2017-2028
Figure 8.8: Europe: Market Dynamics
Figure 8.9: Europe: Patient Monitoring Solutions Market (by Country), 2018 and 2028
Figure 8.10: Germany: Patient Monitoring Solutions Market: 2017-2028
Figure 8.11: U.K.: Patient Monitoring Solutions Market: 2017-2028
Figure 8.12: France: Patient Monitoring Solutions Market: 2017-2028
Figure 8.13: Italy: Patient monitoring Solutions Market: 2017-2028
Figure 8.14: Spain.: Patient Monitoring Solutions Market: 2017-2028
Figure 8.15: Netherlands: Patient Monitoring Solutions Market: 2017-2028
Figure 8.16: Rest-of-the-Europe: Patient Monitoring Solutions Market: 2017-2028
Figure 8.17: Asia-Pacific: Patient Monitoring Solutions Market, 2017-2028
Figure 8.18: Asia-Pacific: Market Dynamics
Figure 8.19: Asia-Pacific: Patient Monitoring Solutions Market (by Country), 2018 and 2028
Figure 8.20: Japan.: Patient Monitoring Solutions Market: 2017-2028
Figure 8.21: China: Patient Monitoring Solutions Market: 2017-2028
Figure 8.22: Australia.: Patient Monitoring Solutions Market: 2017-2028
Figure 8.23: India: Patient Monitoring Solutions Market: 2017-2028
Figure 8.24: South Korea: Patient Monitoring Solutions Market: 2017-2028
Figure 8.25: Rest-of-Asia-Pacific: Patient monitoring solutions Market: 2017-2028
Figure 8.26: Rest-of-the-World: Patient Monitoring Solutions Market, 2017-2028
Figure 8.27: Rest-of-the-World: Market Dynamics
Figure 8.28: Rest-of-the-World: Patient Monitoring Solutions Market (by Country), 2018 and 2028
Figure 8.29: Latin America Patient Monitoring Solutions Market, 2017-2028
Figure 8.30: Middle East & Africa.: Patient Monitoring Solutions Market: 2017-2028
Figure 9.1: Shares of Key Companies Profile
Figure 9.2: Medtronic plc: Overall Product Portfolio
Figure 9.3: Medtronic plc: Overall Financials, 2016-2018
Figure 9.4: Medtronic plc: Revenue (by Product and Services), 2016-2018
Figure 9.5: Medtronic plc: Revenue (by Region), 2016-2018
Figure 9.6: Medtronic plc: R&D Expenditure, 2016-2018
Figure 9.7: Medtronic plc: SWOT Analysis
Figure 9.8: General Electric Company: Overall Product Portfolio
Figure 9.9: General Electric Company: Overall Financials, 2016-2018
Figure 9.10: General Electric Company Net Revenue (by Business Segment), 2016-2018
Figure 9.11: General Electric Company: Net Revenue (by Region), 2016-2018
Figure 9.12: General Electric Company: R&D Expense, 2016-2018
Figure 9.13: General Electric Company: SWOT Analysis
Figure 9.14: Koninklijke Philips N.V.: Overall Product Portfolio
Figure 9.15: Koninklijke Philips N.V.: Overall Financials, 2016-2018
Figure 9.16: Koninklijke Philips N.V. Net Revenue (by Business Segment), 2016-2018
Figure 9.17: Koninklijke Philips N.V.: Net Revenue (by Region), 2016-2018
Figure 9.18: Koninklijke Philips N.V.: R&D Expense, 2016-2018
Figure 9.19: Koninklijke Philips N.V.: SWOT Analysis
Figure 9.20: Drägerwerk AG & Co. KGaA: Overall Product Portfolio
Figure 9.21: Drägerwerk AG & Co. KGaA: Overall Financials (2016-2018)
Figure 9.22: Drägerwerk AG & Co. KGaA: Business Segments (2016-2018)
Figure 9.23: Drägerwerk AG & Co. KGaA: Net Sales by Region (2016-2018)
Figure 9.24: Percent Sales from each Region in 2017
Figure 9.25: Dragerwerk AG & Co. KGaA: SWOT Analysis
Figure 9.26: Abbott Laboratories: Overall Product Portfolio
Figure 9.27: Abbott Laboratories: Overall Financials, 2016-2018
Figure 9.28: Abbott Laboratories: Revenue (by Product and Services), 2016-2018
Figure 9.29: Abbott Laboratories: Revenue (by Region), 2016-2018
Figure 9.30: Abbott Laboartories: R&D Expenditure, 2016-2018
Figure9.31: Abbott Laboratories: SWOT Analysis
Figure 9.32: Johnson & Johnson: Overall Product Portfolio
Figure 9.33: Johnson & Johnson: Overall Financials, 2017-2019
Figure 9.34: Johnson & Johnson: Revenue (by Product and Services), 2016-2018
Figure 9.35: Johnson & Johnson: Revenue (by Region), 2016-2018
Figure 9.36: Johnson & Johnson: R&D Expenditure, 2016-2018
Figure 9.37: Johnson & Johnson: SWOT Analysis
Figure 9.38: F. Hoffmann-La Roche AG: Overall Product Portfolio
Figure 9.39: F. Hoffmann-La Roche AG: Overall Financials, 2016-2018
Figure 9.40: F. Hoffmann-La Roche AG: Revenue (by Segment), 2016-2018
Figure 9.41: F. Hoffmann-La Roche Ltd: Revenue Split for Diagnostics, 2016-2018
Figure 9.42: F. Hoffmann-La Roche AG: Revenue (by Region), 2016-2018
Figure 9.43: F. Hoffmann-La Roche AG: R&D Expenditure, 2016-2018
Figure 9.44: F. Hoffmann-La Roche AG: SWOT Analysis
Figure 9.45: Boston Scientific Corporation: Overall Product Portfolio
Figure 9.46: Boston Scientific Corporation Overall Financials, 2016-2019
Figure 9.47: Boston Scientific Corporation: Revenue (by Product and Services), 2016-2018
Figure 9.48: Boston Scientific Corporation: Revenue (by Region), 2016-2018
Figure 9.49: Boston Scientific Corporation: R&D Expenditure, 2016-2018
Figure 9.50: Boston Scientific Corporation: SWOT Analysis
Figure 9.51: Edwards Lifesciences Corporation: Overall Product Portfolio
Figure 9.52: Edwards Lifesciences Corporation Overall Financials, 2016-2018
Figure 9.53: Edwards Lifesciences Corporation: Revenue (by Product and Services), 2016-2018
Figure 9.54: Edwards Lifesciences Corporation: Revenue (by Region), 2016-2018
Figure 9.55: Edwards Lifesciences Corporation: R&D Expenditure, 2016-2018
Figure 9.56: Edwards Lifesciences Corporation: SWOT Analysis
Figure 9.57: NOHON KOHDEN CORPORATION: Overall Product Portfolio
Figure 9.58: NIHON KOHDEN CORPORATION Overall Financials, 2017-2019
Figure 9.59: NIHON KOHDEN CORPORATION: Revenue (by Product and Services), 2016-2018
Figure 9.60: NIHON KOHDEN CORPORATION: Revenue (by Region), 2016-2018
Figure 9.61: NOHON KOHDEN CORPORATION: R&D Expenditure, 2016-2018
Figure 9.62: NIHON KOHDEN CORPORATION: SWOT Analysis
Figure 9.63: Omron Corporation: Overall Product Portfolio
Figure 9.64: Omron Corporation: Overall Financials, 2016-2019
Figure 9.65: Omron Corporation: Revenue (by Product and Services), 2016-2018
Figure 9.66: Omron Corporation: Revenue (by Region), 2016-2018
Figure 9.67: Omron Corporation: R&D Expenditure, 2016-2018
Figure 9.68: Omron Corporation: SWOT Analysis
Figure 9.69: Bosch Limited: Overall Product Portfolio
Figure 9.70: Bosch Limited Overall Financials, 2016-2019
Figure 9.71: Bosch Limited: Revenue (by Product and Services), 2016-2018
Figure 9.72: Bosch Limited: Revenue (by Region), 2016-2018
Figure 9.73: Bosch Limited: R&D Expenditure, 2016-2018
Figure 9.74: Bosch Limited: SWOT Analysis
Figure 9.75: Becton, Dickinson & Company: Overall Product Portfolio
Figure 9.76: Becton, Dickinson & Company Overall Financials, 2016-2019
Figure 9.77: Becton, Dickinson & Company: Revenue (by Product and Services), 2016-2018
Figure 9.78: Becton, Dickinson & Company: Revenue (by Region), 2016-2018
Figure 9.79: Becton, Dickinson & Company: R&D Expenditure, 2016-2018
Figure 9.80: Becton, Dickinson & Company: SWOT Analysis
Figure 9.81: Biotronik: Overall Product Portfolio
Figure 9.82: Biotronik: SWOT Analysis
Figure 9.83: Welch Allyn: Overall Product Portfolio
Figure 9.84: Welch Allyn: SWOT Analysis
Figure 9.85: Smiths Medical, Inc: Overall Product Portfolio
Figure 9.86: Smiths Medical, Inc.: SWOT Analysis
Figure 9.87: Getinge AB: Overall Product Portfolio
Figure 9.88: Getinge AB: SWOT Analysis
Figure 9.89: Spacelabs Healthcare: Overall Product Portfolio
Figure 9.90: Spacelabs Healthcare: SWOT Analysis
Figure 10.1: Global Patient Monitoring Solutions: Market Segmentation
Figure 10.2: Global Patient Monitoring Solutions Market
Figure 10.3: Data Triangulation
Figure 10.4: Top-Down Approach (Segment-Wise Analysis)
Figure 10.5: Bottom-up Approach (Segment-wise Analysis)
Figure 10.6: Assumptions and Limitations
Figure 10.7: Data and Prediction Modeling
LOADING...
FEATURED COMPANIES
- Abbott Laboratories
- Bosch Limited
- F. Hoffmann-La Roche Ltd
- Getinge AB
- Koninklijke Philips N.V.
- NIHON KOHDEN CORPORATION
According to the market intelligence report, "Global Patient Monitoring Solutions Market- Analysis and Forecast, 2019-2028", the global patient monitoring solutions market generated a revenue of $19.30 billion in 2018 and is estimated to grow over $36.13 billion by the end of 2028. The market is projected to grow at a CAGR of 6.50%, during the forecast period from 2019 to 2028. There are multiple factors that drive this market such as increase in the geriatric populations, growing prevalence of chronic diseases and rise in adoption rate of remote patient monitoring devices.
The report provides varied segmentation of the market done on the basis of product, application, end-user, and region. In the case of product type, various devices are used hemodynamic, cardiac, respiratory, neuromonitoring, diabetes and temperature monitoring devices. In the case of application, hematology, cardiology, respiratory, neurology, temperature, and metabolics are used.
Moreover, the market is also categorized on the basis of end-user into hospital-based patients, ambulatory based patients, and home healthcare patients. Several companies and start-ups are based out of the developed regions, such as North America and Europe.
According to Nitish Singh, the Analyst, “North America is the leading contributor to the global patient monitoring solutions market. In 2018, in terms of revenue, the North America patient monitoring solutions market was valued $8.14 billion which is anticipated to grow at a CAGR of 6.13% during the forecast period. This double-digit growth can be attributed to the rising demand for home-based monitoring devices and increasing investment in healthcare IT. However, Asia-Pacific is the fastest-growing region growing with a CAGR of 7.05% during the forecast period, because of the rising prevalence of chronic diseases such as diabetes, and hypertension and rising demand for home-based monitoring devices.”
The following are the research highlights:
- The Global Patient Monitoring Solutions Market can be segmented on the basis of “Product”, “Application”, “End-User”, and “Region”.
- As of 2018, the global patient monitoring solutions market was estimated to be approximately $19.30 billion and is expected to reach a value of an estimated $36.13 billion by the end of 2028, growing with a double-digit CAGR during the forecast period.
- North America dominated the patient monitoring solutions market and accounted for 42.18% in 2018, and 40.74% during the upcoming year 2028.
- Factors contributing to the growth of the North America patient monitoring solutions market include rising demand for home-based monitoring devices and increasing investment in healthcare IT.
- Asia-Pacific held the second largest contributor for the patient monitoring solutions market, due to the increasing prevalence of chronic conditions such as diabetes and hypertension and rising demand for home-based monitoring devices.
- The global patient monitoring solutions market is segmented based on products (hemodynamic, cardiac, neuromonitoring, respiratory, diabetes, and temperature monitoring device), applications (hematology, cardiology, respiratory, neurology, metabolics, and temperature), and end-user (hospital-based patients, ambulatory based patients, and home healthcare patients), and region (North America, Europe, Asia-Pacific, and Rest-of-the-World (Latin America and Middle East & Africa).
- By Product, hemodynamic monitoring devices held 28.57% of the market share in 2018. Cardiac monitoring device held 24.62% of the total market share in 2018 and is expected to grow in the upcoming years. The growth in the segment can be attributed to the availability of blood pressure measuring devices in the hospitals, homes as well as in ambulances, where these devices measure the basic vital signs of the patient such as blood pressure. Additionally, demand for these devices is increasing day by day due to the low price of blood pressure measuring devices and increased usage in the population.
- By Applications, hematology segment held the largest market share with 26.33%, cardiology segment held the second largest market share with 24.54% in 2018.
- By End-User, hospital-based patients dominated the market in 2018 and held the largest market share with 41.90%. The hospital-based patients’ segment is however expected to dominate the market attributing to the patients undergo surgery in the hospitals and hence they need continuous monitoring of the vital signs and their disease condition. Therefore, increasing usage of monitoring devices to hospital-based patients.
This market intelligence report provides a multi-dimensional view of the global patient monitoring solutions market in terms of market size and growth potential. This research report aims at answering various aspects of the global patient monitoring solutions market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion.
Furthermore, the competitive landscape chapter in the report explicates the competitive nature of the global market and enables the reader to get acquainted with the recent market activities, such as product launches, partnerships, collaborations, business expansions, and mergers and acquisitions.
This report is a meticulous compilation of research on 46 players in the market ecosystem and draws upon the insights from in-depth interviews with the key opinion leaders of more than 18 leading companies, market participants, and vendors. The report also profiles 19 companies that comprise key players from the patient monitoring solutions market. Some of the market players include primary and secondary data analysis tools providers such as Medtronic plc, Koninklijke Philips N.V., Abbott Laboratories, F. Hoffmann-La Roche AG, General Electric Company, Omron Corporation, Nihon Kohden Corporation, Boston Scientific Corporation, and Biotronik. There are a plethora of companies providing different products such as Medtronic plc, Natus Medical, and Drägerwerk AG & Co. KGaA.
Key questions answered in the report:
- What are the major market drivers, challenges, and opportunities in the global patient monitoring solutions market?
- What is the global patient monitoring solutions market size in terms of revenue from 2018-2028?
- How is each segment of the global patient monitoring solutions market expected to grow during the forecast period and what is the revenue expected to be generated by each of the segments by the end of 2028?
- What are the key development strategies implemented by the key major players to sustain in the competitive market?
- What is the growth potential of the patient monitoring solutions market in each region, namely, North America, Europe, Asia-Pacific, and the Rest-of-the-World?
- Which products (hemodynamic, cardiac, respiratory, and neuromonitoring devices) are offered by key players such as GE Healthcare, Medtronic plc, Biotronik Scientific Corporation, Koninklijke Philips N.V., and Johnson & Johnson?
- What is the market share of major companies in the global patient monitoring solutions market?
- Which product is currently dominating the global patient monitoring solutions market and why?
- Which application and end-user of the global patient monitoring solutions market are dominant in the forecast period?
- Medtronic plc
- General Electric Company
- Koninklijke Philips N.V.
- Drägerwerk AG & Co. KGaA
- Abbott Laboratories
- Johnson & Johnson
- F. Hoffmann-La Roche Ltd
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- NIHON KOHDEN CORPORATION
- Omron Corporation
- Bosch Limited
- Becton, Dickinson, and Company
- Biotronik
- Welch Allyn
- Smiths Medical, Inc.
- Getinge AB
- Spacelabs Healthcare
-
